98371742 - QURE

Information

  • Trademark
  • 98371742
  • Serial Number
    98371742
  • Filing Date
    January 23, 2024
    2 years ago
  • Transaction Date
    May 08, 2025
    11 months ago
  • Status Date
    November 05, 2024
    a year ago
  • Location Date
    May 08, 2025
    11 months ago
  • Status Code
    653
  • Current Location
    TMO LAW OFFICE 130
    Employee Name
    LINCOSKI JR,JOHN T
  • Attorney Docket Number
    115710.01079
    Attorney Name
    Erica R. Halstead
  • Owners
Mark Drawing Code
4
Mark Identification
QURE
Case File Statements
  • GS0051: Viral systems, gene therapy systems, nucleic acid delivery systems, all comprised of biological preparations in the nature of viruses for medical purposes; viral vectors, gene therapy vectors, nucleic acid delivery vectors, all comprised of biological preparations in the nature of viruses for medical purposes; pharmaceutical products for the treatment of diseases; biological preparations for use in medical purposes, namely, in medical and clinical gene therapy, nucleic acid-based therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, gene diagnosis and gene testing; pharmaceutical preparations being prophylaxis products for use in nucleic acid-based therapy and gene therapy
  • GS0011: Viral systems, gene therapy systems, and nucleic acid delivery systems, all comprised of biological preparations in the nature of viruses for use in cell cultures for non-medical, scientific research purposes; viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors all comprised of biological preparations in the nature of viruses for use in cell cultures for non-medical, scientific research purposes
  • GS0441: Medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders using gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation; Providing medical information and advice in the field of medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders using gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation
  • TR0000: The wording QURE has no meaning in a foreign language.
  • GS0421: Medical and scientific research, product development and consultancy in the fields of biotechnology, biology, biopharmaceutical research and development, medical science, chemistry and biochemistry; Providing medical and scientific research information and advice in the fields of biotechnology, biology, biopharmaceutical research and development, medical science, chemistry and biochemistry
Case File Event Statements
  • 1/23/2024 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/24/2024 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/19/2024 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/15/2024 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/16/2024 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/27/2024 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/27/2024 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/27/2024 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/15/2024 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/5/2024 - a year ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 11/5/2024 - a year ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 11/5/2024 - a year ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 4/1/2025 - a year ago
    13 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/8/2025 - 11 months ago
    14 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK